Penile cancer remains a relatively infrequent malignancy in North America, Europe, and Asia nevertheless it is a devastating disease which portends an adverse prognosis in those presenting with advanced disease. Similarly, the clinical and surgical care remains highly diverse across many parts of the world often applying non-evidence based approaches in their management.